Acarix A/S
Save
268.06M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Devices
Industry
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
Similar securities
Based on sector and market capitalization
Report issue